The failure to decrease cell proliferation is consistent with previous reports indicating that the major effect of PD-1/PD-L1 blockade is through the rejuvenation of effector functions of CD8+ T cells and its tumor lytic activity [14,48]. Here, CD8A is linked to neoplasm.